• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Oct23
Fangsheng Pharmaceutical released FY2025 9 Months earnings on October 23 After-Market (BJT), actual revenue CNY 1.253 B, actual EPS CNY 0.6091
01:00
Fangsheng Pharmaceutical released FY2025 Q3 earnings on October 23 After-Market (BJT), actual revenue CNY 419.07 M, actual EPS CNY 0.2193
01:00
Oct16
Fangsheng Pharmaceutical to Release FY2025 Q3 Earnings on October 24 After-Market (BJT)
00:19
Aug28
Fangsheng Pharmaceutical released FY2025 Semi-Annual Earnings on August 28 After-Market (BJT), Actual Revenue: CNY 834.25M, Actual EPS: CNY 0.39
01:00
Fangsheng Pharmaceutical released FY2025 Q2 earnings on August 28 After-Market (BJT), actual revenue CNY 416.17 M, actual EPS CNY 0.1898
01:00
Aug21
Fangsheng Pharmaceutical to Release FY2025 Semi-Annual Earnings on August 29, 2025 (BJT)
00:42

Schedules & Filings

Schedules
Filings
Oct23
Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 419.07 M, Net Income 99.04 M, EPS 0.2193

Sep18
Distribution Plan(CST)

Cash dividend 0.15 CNY

Distribution Plan(CST)

Cash dividend 0.15 CNY

View More

Stock List

Top Gainers
Top Decliners
Northbound Connect
Symbol
Price
%Chg
Change
View More